Related by context. Frequent words. (Click for all words.) 62 metastatic castration resistant 61 pertuzumab 61 metastatic hormone refractory 61 HER2 positive metastatic breast 61 Irinotecan 60 neoadjuvant chemotherapy 60 exemestane 60 neoadjuvant 59 recurrent glioblastoma 59 goserelin 59 lymphopenia 59 Dasatinib 59 cervical intraepithelial neoplasia 58 tibolone 58 tamoxifen therapy 58 fibrinolysis 58 sunitinib malate 58 decitabine 58 Denufosol 58 enzastaurin 57 severe renal insufficiency 57 immunostaining 57 IMC A# 57 elotuzumab 57 ximelagatran 57 metabolic parameters 57 severe renal impairment 57 TRITON TIMI 56 Generalized Anxiety Disorder 56 Atopic Dermatitis 56 Randomized controlled 56 Tacrolimus 56 HSCT 56 refractory chronic lymphocytic 56 II Clinical Trial 56 ethambutol 56 tanespimycin 56 APTIVUS 56 teriflunomide 56 phase Ib 55 QTc prolongation 55 beta blocker therapy 55 subanalysis 55 double blinded placebo 55 biochemical recurrence 55 cardiac dysfunction 55 Phase Ib II 55 secondary hyperparathyroidism 55 CALGB 55 forodesine 55 castration resistant prostate cancer 55 ropinirole 55 placebo controlled clinical 55 immunohistochemical 55 Aliskiren 55 dose titration 55 YERVOY 55 neoadjuvant therapy 55 Amrubicin 55 paclitaxel eluting stents 55 hepatocellular cancer 55 PsA 54 Etanercept 54 virologic failure 54 olaparib 54 heavily pretreated 54 randomized multicenter 54 DMSA 54 anticholinergics 54 TACI Ig 54 dyspareunia 54 mRCC 54 ongoing Phase 1b 54 juvenile idiopathic arthritis 54 multicenter Phase 54 lymphadenectomy 54 Idiopathic 54 cystectomy 54 AVANDIA 54 heavily pretreated patients 54 cytogenetic response 54 Antipsychotics 54 Traficet EN 53 Abacavir 53 Epratuzumab 53 RTOG 53 tigecycline 53 distant metastases 53 HBsAg 53 Zolinza 53 phase IIb clinical 53 INCB# [001] 53 Polymorphism 53 Panitumumab 53 XIENCE V demonstrated 53 prospective observational 53 virological failure 53 leukemia ALL 53 darapladib 53 RRMS patients 53 NMP#